PLEUROPULMONARY DISEASE ASSOCIATED WITH DOPAMINE AGONIST THERAPY

被引：60
作者：
BHATT, MH
KEENAN, SP
FLEETHAM, JA
CALNE, DB
机构：
[1] UNIV BRITISH COLUMBIA,DEPT MED,BELZBERG LAB CLIN NEUROSCI,VANCOUVER V6T 1W5,BC,CANADA
[2] UNIV BRITISH COLUMBIA,DEPT MED,DIV RESP MED,VANCOUVER V6T 1W5,BC,CANADA
来源：
ANNALS OF NEUROLOGY | 1991年 / 30卷 / 04期
关键词：
D O I：
10.1002/ana.410300416
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Artificial dopamine agonists are widely employed for the treatment of idiopathic parkinsonism. Pleuropulmonary disease has previously been reported to occur with the use of bromocriptine and mesulergine. We report similar adverse effects induced by the newer agonists lisuride and cabergoline. All these agents are tetracyclic ergot derivatives. This suggests a causal link between ergot-derived dopamine agonists and pleuropulmonary disease.
引用
收藏
页码：613 / 616
页数：4
相关论文
共 16 条
  • [1] CALNE DB, 1983, LISURIDE OTHER DOPAM, P1
  • [2] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS
    CORRODI, H
    FUXE, K
    HOKFELT, T
    LIDBRINK, P
    UNGERSTEDT, U
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) : 409 - 412
  • [3] RETROPERITONEAL FIBROSIS AND TREATMENT OF PARKINSONS-DISEASE WITH HIGH-DOSES OF BROMOCRIPTINE
    DEMONET, JF
    ROSTIN, M
    DUEYMES, JM
    IOUALALEN, A
    MONTASTRUC, JL
    RASCOL, A
    [J]. CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) : 200 - 201
  • [4] LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS
    FERRARI, C
    BARBIERI, C
    CALDARA, R
    MUCCI, M
    CODECASA, F
    PARACCHI, A
    ROMANO, C
    BOGHEN, M
    DUBINI, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) : 941 - 945
  • [5] Gopinathan G, 1989, HDB EXPT PHARM, V88, P471
  • [6] GRAHAM JR, 1967, AM J MED SCI, V254, P1
  • [7] GRAHAM JR, 1966, NEW ENGL J MED, V274, P358
  • [8] LEWITT PA, 1981, LANCET, V1, P44
  • [9] LEWITT PA, 1981, J NEURAL TRANSM, V143, P2648
  • [10] PLEUROPULMONARY DISEASE DURING BROMOCRIPTINE TREATMENT OF PARKINSON DISEASE
    MCELVANEY, NG
    WILCOX, PG
    CHURG, A
    FLEETHAM, JA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (10) : 2231 - 2236
12